Valuation dashboard for 908 Devices Inc. (MASS) with P/E N/A, P/B 3.10, EV/EBITDA -11.15 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable...
Analysis Summary
908 Devices Inc. reported revenue of $56.2M in the most recent fiscal year, growing at a 5-year CAGR of 15.9%.
Trailing-twelve-month margins: gross margin 49.8%, operating margin -46.0%, net margin -56.7%.
At the current price of $10.53, MASS has negative trailing earnings (P/E not meaningful) and an ROE of -25.50%. Market capitalisation stands at $432M.
Balance sheet quality for MASS: current ratio of 4.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.10 |
| EV / EBITDA | -11.15 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-7.98 |
| vs Current Price | -175.8% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| MASS | 908 Devices Inc. | $450M | 3.10 | -25.5% | |
| ALC | Alcon Inc. | $31.8B | 51.18 | 1.50 | |
| 0A0D.L | Alcon Inc. | $27.0B | |||
| STE | STERIS plc | $20.3B | 25.60 | 2.84 | 11.3% |
| 0JZ2.L | Masimo Corporation | $9.5B | |||
| 0QLQ.L | Ypsomed Holding AG | $4.7B | |||
| 0A05.L | Medacta Group S.A. | $2.2B |
Price
| Price | $10.53 |
| Market Cap | $432M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -25.50% |
| Return on Invested Capital | -18.70% |
| Return on Assets | -17.46% |
| Gross Margin | 49.79% |
| Operating Margin | -46.01% |
| Net Margin | -56.68% |
Related companies: ACRS · CAPR · CERS · CVRX · NNOX · NPCE · QTRX
Explore sector: Healthcare · Medical - Specialties
More sections of MASS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks